Avalon GloboCare Corp. is a commercial-stage company engaged in developing and delivering precision diagnostic consumer products and the advancement of intellectual property in cellular therapy. The Company operates in two reportable business segments: the real property operating segment and the laboratory testing services segment. Its laboratory services offer a test menu that satisfies the clients' testing needs, from general bloodwork to anatomic pathology, urine toxicology, pharmacogenomics (PGx) testing and more, and it is a one-stop-shop for clinical testing. The Company is currently marketing the KetoAir breathalyzer device and plans to develop additional diagnostic uses of the breathalyzer technology. The KetoAir breathalyzer is a handheld device that allows the user to detect acetone levels in exhaled breath. The acetone level is in concentration units part-per-million (ppm) such that the user knows the real-time ketosis status.
종목 코드 ALBT
회사 이름Avalon Globocare Corp
상장일Feb 22, 2016
CEOJin (David)
직원 수5
유형Ordinary Share
회계 연도 종료Feb 22
주소4400 Route 9
도시FREEHOLD
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호07728
전화17327804400
웹사이트https://www.avalon-globocare.com/
종목 코드 ALBT
상장일Feb 22, 2016
CEOJin (David)
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음